NCT05696392: An ongoing trial by Incyte Corporation
This trial is ongoing. It must report results 1 month, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05696392 |
|---|---|
| Title | An Open-Label, Single-Arm, Phase 4 Study of Ruxolitinib Cream in Adults With Atopic Dermatitis Experiencing Sleep Disturbance in the United States (MORPHEUS) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 16, 2023 |
| Completion date | Jan. 22, 2025 |
| Required reporting date | Jan. 22, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |